HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 20, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2021 , after the close of market on Tuesday, July 27, 2021 .
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 14, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that it has accepted the resignation of its Chief Financial Officer, Daphne Huang , effective August 6, 2021 . Ms.
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jun. 18, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 , filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 19, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2021 . Quarter ended March 31, 2021 Highlights ─ compared to March 31, 2020 Net sales of
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 12, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2021 , on Wednesday, May 19, 2021 . The release will be accessible on Taro’s website at www.taro.com .
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 27, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2020 . Quarter ended December 31, 2020 Highlights ─ compared to December 31,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 20, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2020 , after the close of market on Wednesday, January 27, 2021 .
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 28, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2020 . Quarter ended September 30, 2020 Highlights ─ compared to September 30,
Earnings Call on Thursday, October 29th at 8:00 am ET HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 21, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2020 , on Wednesday, October
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Sep. 28, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or “the Company”) today announced the launch of a new specialty generic, deferiprone, an iron chelator indicated for the treatment of patients with transfusional iron overload due to
Alerts are e-mailed to you whenever certain new company information is posted to this site.
